Zomedica Corp.
ZOMDF
$0.11
-$0.01-4.97%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.10M | 6.96M | 6.50M | 7.90M | 7.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.10M | 6.96M | 6.50M | 7.90M | 7.00M |
| Cost of Revenue | 2.66M | 2.30M | 2.09M | 2.35M | 1.94M |
| Gross Profit | 5.44M | 4.67M | 4.41M | 5.55M | 5.06M |
| SG&A Expenses | 10.26M | 10.82M | 11.27M | 11.56M | 10.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.70M | 15.00M | 15.22M | 16.06M | 14.44M |
| Operating Income | -6.61M | -8.04M | -8.72M | -8.16M | -7.44M |
| Income Before Tax | -6.14M | -7.39M | -63.87M | -7.42M | -6.72M |
| Income Tax Expenses | -19.00K | 12.00K | -57.00K | -221.00K | -27.00K |
| Earnings from Continuing Operations | -6.12M | -7.40M | -63.81M | -7.19M | -6.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.12M | -7.40M | -63.81M | -7.19M | -6.70M |
| EBIT | -6.61M | -8.04M | -8.72M | -8.16M | -7.44M |
| EBITDA | -4.71M | -6.11M | -6.50M | -6.11M | -5.41M |
| EPS Basic | -0.01 | -0.01 | -0.07 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.07 | -0.02 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 979.95M | 979.95M | 979.95M | 979.95M | 979.95M |
| Average Diluted Shares Outstanding | 979.95M | 979.95M | 979.95M | 979.95M | 979.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |